BTC $71,807
2026 Bull Run Is Building Start trading with 5% OFF all fees
Sign Up Now
BTC $71,807
Bull Run 2026 | 5% Off Fees Open your Binance account today
Sign Up

Nvidia Gains After $20B Groq Licensing Deal for Inference AI

Nvidia, Sidus Space, Coupang, Vanda Pharmaceuticals and ImmuCell

  • Stocks rose midday Friday as U.S. markets reopened after the Christmas holiday, with the S&P 500 hitting a fresh high.
  • NVIDIA agreed to a non‑exclusive licensing deal for its inference technology valued at about $20 billion, lifting its shares nearly 2%.
  • Sidus Space, Coupang, Vanda Pharmaceuticals and ImmuCell all saw notable gains after company‑specific news.

U.S. equities traded higher midday Friday as investors returned after the Christmas holiday and the S&P 500 notched a new all‑time high. Markets showed modest ETF gains: the SPDR S&P 500 ETF (SPY) rose 0.08%, the Invesco QQQ Trust (QQQ) gained 0.16%, and the SPDR Dow Jones Industrial Average ETF Trust (DIA) climbed 0.01%.

- Advertisement -

Nvidia Corp. shares rose nearly 2% after the company entered a non‑exclusive licensing agreement with Groq for its inference technology, a deal valued at about $20 billion. Inference technology is software and models that run trained artificial‑intelligence systems to produce outputs from input data.

Sidus Space Inc. jumped more than 22% midday after the firm was awarded a contract under the Missile Defense Agency’s Scalable Homeland Innovative Enterprise Layered Defense (SHIELD) program. SIDU stock has climbed about 237% over the past five trading sessions.

According to Reuters, Coupang Inc. rose over 9% after the company said that “all leaked customer information has been deleted”; Coupang stated the suspect was a former employee. CPNG is up roughly 10% over the past five trading sessions.

Vanda Pharmaceuticals Inc. gained nearly 8% in premarket trading before settling about 3% higher as investors awaited an upcoming U.S. Food and Drug Administration decision on Tradipitant, a motion‑sickness prevention drug. VNDA is up 7% over five sessions.

- Advertisement -

ImmuCell Corp. rose nearly 10% midday after announcing a 50% expansion of its First Defense field sales force and plans to scale up drug manufacturing; the company also said it is pausing its Re‑Tain treatment for cows after receiving an “Incomplete Letter” from the FDA. ICCC is up about 2% over the past five trading sessions.

✅ Follow BITNEWSBOT on Telegram, Facebook, LinkedIn, X.com, and Google News for instant updates.

Previous Articles:

- Advertisement -
Ad
Altseason Is Loading. Don't watch from the sidelines.
SOL $90.51
DOGE $0.0963
LINK $9.02
SUI $1.00
5% off fees when you sign up
Start Trading
Ad
Pay Less on Every Trade. For Life.
$10K/mo volume Save $60/yr
$50K/mo volume Save $300/yr
$100K/mo volume Save $600/yr
5% off all trading fees when you sign up
Claim Your Discount

Latest News

Cambridge: Ethereum Energy Intensity Low, Overall Use High

Ethereum consumes roughly 7.87 GWh annually, the second-lowest energy intensity per market value among...

Saylor and Back oppose BIP-110 fork over Bitcoin security fears

Michael Saylor and Adam Back have publicly opposed BIP-110, a temporary Bitcoin fork proposal...

China, India groups target Pakistani police in cyber espionage

Suspected China- and India-aligned threat actors targeted Pakistani law enforcement in a sustained cyber...

AMD Stock Dips 10% Amid AI Volatility Ahead of Q3 Earnings

AMD stock fell nearly 10% from $580 on June 30 to roughly $516 by...

Bitcoin Creator Back Warns BIP-110 Data Limit Could Split Network

Adam Back said Bitcoin has "robustly rejected" BIP-110, arguing the proposal conflicts with the...

Must Read

Tutorial: How to Buy a Domain Name Permanently? (Super Easy)

Are you ready to establish a permanent online presence and you want to buy a domain forever?In this tutorial, we'll show you how to...
Ad
Altseason Is Loading. These 4 coins are trending right now.
SOL $92.12
DOGE $0.0950
LINK $9.02
SUI $1.02
5% off spot fees when you sign up
Start Trading